ACM
NKTR icon

Aquatic Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Aquatic Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.1M Buy
57,014
+1,774
+3% +$101K 0.12% 230
2025
Q4 		$2.34M Buy
+55,240
New +$3.09M 0.07% 345
2023
Q1 		– Sell
-4,633
Closed -$157K – 1595
2022
Q4 		$157K Buy
4,633
+2,626
+131% +$127K 0.01% 786
2022
Q3 		$96K Buy
+2,007
New +$119K 0.01% 759

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aquatic Capital Management's NKTR Position: Q1 2026 in Review

Aquatic Capital Management increased its Nektar Therapeutics (NKTR) stake by 3.2% in Q1 2026, buying an estimated $101K and bringing the position to 57,014 shares worth $4.1M. The position accounts for 0.12% of the portfolio, ranked #230.

Aquatic Capital Management first reported a position in NKTR in Q3 2022 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Aquatic Capital Management held 57,014 shares of Nektar Therapeutics worth $4.1M as of Q1 2026.
  • Aquatic Capital Management bought 1,774 Nektar Therapeutics shares in Q1 2026, an estimated $101K.
  • Nektar Therapeutics made up 0.12% of Aquatic Capital Management's portfolio in Q1 2026, its #230 holding.
  • Aquatic Capital Management first reported a position in Nektar Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.